Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Cardiovascular Risk and Fatty Liver Disease

Importance of Early & Effective Treatment of Mild to Moderate Acne

SGLT2s and Renal Protection

CV Medications – Practical Strategies to Improve Compliance

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis